XSHE
300487
Market cap4.93bUSD
Oct 09, Last price
65.46CNY
1D
1.07%
1Q
-19.08%
Jan 2017
553.95%
IPO
1,466.03%
Name
Sunresin New Materials Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sunresin New Materials Co.,Ltd, a Chinese company, specializes in the research, development, production, and sale of advanced adsorption and separation materials, along with integrated exchange separation system devices. Its extensive product portfolio features a wide array of specialized resins, including adsorbent, catalyst, chelating, powder, and various strong and weak acid cation/anion ion exchange types, as well as mixed bed resins. The company also provides chromatographic media, enzyme carriers, and essential products for solid-phase peptide synthesis. Furthermore, Sunresin offers "Sepsolut," a comprehensive ion exchange and adsorbent system and solution. These versatile products are crucial for numerous sectors such as food and beverage, biopharmaceuticals and life sciences, botanical extraction, municipal and industrial water purification, chemical processing, hydrometallurgy and mining, and wastewater treatment and recycling. Established in 2001, Sunresin New Materials Co.,Ltd maintains its headquarters in Xi'an, China.
Key people
Fumin Guo
Deputy General Manager · since 2020
Risheng Wang
Deputy General Manager · since 2021
Weijun Wei
Deputy General Manager, Director · since 2011
Yang Yu
Deputy General Manager, Secretary of the Board · since 2021
Yuan An
Chief Financial Officer, Director · since 2019
Yuejing Gao
Chairman of the Board
Xiaokang Kou
General Manager, Director · since 2011
Suidang Li
Director · since 2019
Xiaojun Tian
Deputy General Manager, Director · since 2011
Jing Li
Independent Director · since 2021
Li Qiang
Independent Director · since 2021
Youlong Xu
Independent Director · since 2021
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||